Anika Therapeutics Inc. - Common Stock (NQ:ANIK)

19.10 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Anika Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Anika Therapeutics Earnings Preview ↗

March 03, 2023

Via Benzinga

Anika to Participate in the Canaccord Genuity Musculoskeletal Conference

February 28, 2023

From Anika Therapeutics Inc.

Via GlobeNewswire

Anika to Issue Fourth Quarter and Year-End 2022 Financial Results on Monday, March 6, 2023

February 21, 2023

From Anika Therapeutics Inc.

Via GlobeNewswire

Anika Issues Statement

February 21, 2023

From Anika Therapeutics Inc.

Via GlobeNewswire

New FDA 510(k) Clearance Expands Anika's Sports Medicine Soft Tissue Portfolio ↗

May 20, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

March 11, 2022

During Friday's session, 198 companies made new 52-week lows. Key Facts About Today's 52-Week Highs And Lows: Alibaba Group Holding (NYSE:BABA) is the largest...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

February 04, 2022

On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap...

Via Benzinga

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Anika Announces First Surgeries Performed Using the New RevoMotion™ Reverse Shoulder Arthroplasty System and Commences Limited Market Release in the United States

February 13, 2023

From Anika Therapeutics Inc.

Via GlobeNewswire

7 Stocks to Buy Before the Market Starts to Soar in 2023 ↗

November 10, 2022

With the market falling into a bit of disarray, astute investors can leverage this moment to dive into compelling stocks to buy.

Via InvestorPlace

Anika Therapeutics Cingal Tops Steroid For Osteoarthritis Pain Relief ↗

November 01, 2022

Via Benzinga

Anika’s Cingal® Successfully Achieves Primary Endpoint in Third Phase III Study

November 01, 2022

From Anika Therapeutics Inc.

Via GlobeNewswire

Anika to Issue Third Quarter 2022 Financial Results on Tuesday, November 8, 2022

October 25, 2022

From Anika Therapeutics Inc.

Via GlobeNewswire

Anika Therapeutics: Q2 Earnings Insights ↗

August 03, 2022

Anika Therapeutics (NASDAQ:ANIK) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

Anika Receives the ACE Award for Cutting-Edge Innovation for Tactoset® Injectable Bone Substitute from the American Orthopedic Society for Sports Medicine

July 27, 2022

From Anika Therapeutics Inc.

Via GlobeNewswire

Sidoti's Summer Small Cap Virtual Conference

June 14, 2022

NEW YORK, NY / ACCESSWIRE / June 14, 2022 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day Summer Small Cap Virtual Conference taking place Wednesday and...

From Sidoti & Company, LLC

Via AccessWire

Stocks That Hit 52-Week Lows On Wednesday ↗

March 09, 2022

During Wednesday's session, 35 companies made new 52-week lows. 52-Week High And Low Highlights: The company with the largest market cap to set a new 52-week low was...

Via Benzinga

Anika Therapeutics: Q4 Earnings Insights ↗

March 08, 2022

Anika Therapeutics (NASDAQ:ANIK) reported its Q4 earnings results on Tuesday, March 8, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout ↗

March 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative...

Via Benzinga

Anika Therapeutics, inc (ANIK) Q3 2021 Earnings Call Transcript ↗

November 05, 2021

ANIK earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Return on Capital Employed Insights for Anika Therapeutics ↗

August 23, 2021

After pulling data from Benzinga Pro it seems like during Q2, Anika Therapeutics (NASDAQ:ANIK) earned $9.18 million, a 629.73% increase from the preceding quarter. Anika...

Via Benzinga

Anika Therapeutics, inc (ANIK) Q2 2021 Earnings Call Transcript ↗

August 06, 2021

ANIK earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Earnings Scheduled For March 8, 2022 ↗

March 08, 2022

Companies Reporting Before The Bell • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million. •...

Via Benzinga

The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg ↗

March 06, 2022

Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (...

Via Benzinga

The Daily Biotech Pulse: FDA Nod For Novartis, iRhythm CEO Quits Abruptly, Moderna Inks Vaccine Supply Agreements ↗

June 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 1) Anika Therapeutics, Inc. (...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

February 03, 2022

On Thursday, 105 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows And Highs: Meta Platforms (NASDAQ:FB) was the biggest company on...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2021 ↗

November 16, 2021

Upgrades According to Maxim Group, the prior rating for VirTra Inc (NASDAQ:

Via Benzinga

Anika Therapeutics Inc (ANIK) Q1 2021 Earnings Call Transcript ↗

May 07, 2021

ANIK earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 16, 2021 ↗

July 16, 2021

Upgrades According to Citigroup, the prior rating for Alcoa Corp (NYSE:

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.